Long-Term Outcomes with Drug-Eluting Stents versus Bare-Metal Stents in Sweden
Top Cited Papers
Open Access
- 8 March 2007
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 356 (10) , 1009-1019
- https://doi.org/10.1056/nejmoa067722
Abstract
Recent reports have indicated that there may be an increased risk of late stent thrombosis with the use of drug-eluting stents, as compared with bare-metal stents.Keywords
This publication has 24 references indexed in Scilit:
- Late Thrombosis of Drug-Eluting Stents: A Meta-Analysis of Randomized Clinical TrialsPublished by Elsevier ,2006
- Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysisEuropean Heart Journal, 2006
- Three-Year Clinical Follow-Up of the Unrestricted Use of Sirolimus-Eluting Stents as Part of the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) RegistryThe American Journal of Cardiology, 2006
- Pathology of Drug-Eluting Stents in HumansJournal of the American College of Cardiology, 2006
- Safety of Coronary Sirolimus-Eluting Stents in Daily Clinical PracticeCirculation, 2006
- What is the risk of stent thrombosis associated with the use of paclitaxel-eluting stents for percutaneous coronary intervention?: A meta-analysisJournal of the American College of Cardiology, 2005
- A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stentsThe Lancet, 2004
- Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting StentCirculation, 2004
- A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary ArteryNew England Journal of Medicine, 2003